NEW YORK, Oct. 12, 2026 /PRNewswire/ — The Board of Trustees of New York Blood Center Enterprises (NYBCe) has appointed Meghan Delaney, DO, MPH, as the organization’s next President and Chief Executive Officer following an extensive national search. Dr. Delaney will assume the role on January 4, 2027, succeeding Christopher D. Hillyer, MD, who has led the organization since 2009.
Dr. Hillyer will transition to the role of Special Advisor to NYBCe’s Board of Trustees. In this capacity, he will work closely with Dr. Delaney to support a smooth transition while continuing to provide strategic guidance to the Board and NYBCe leadership, ensuring the organization continues to benefit from his experience, expertise, and deep institutional knowledge. READ MORE